Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

61.09
+0.91001.51%
Post-market: 61.05-0.0401-0.07%19:59 EST
Volume:18.54M
Turnover:1.14B
Market Cap:123.97B
PE:-13.84
High:63.11
Open:60.45
Low:60.27
Close:60.18
Loading ...

Trump faces pressure from US industry over China tariff on medicines

Reuters
·
07 Feb

Cytokinetics share weakness on updated Camzyos REMS overdone, says Truist

TIPRANKS
·
06 Feb

Bristol Myers Squibb Shares Down 2.4% After Co Forecasts 2025 Profit, Revenue Below Estimates

THOMSON REUTERS
·
06 Feb

Bristol-Myers Squibb Co reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Feb

Here's What Key Metrics Tell Us About Bristol Myers (BMY) Q4 Earnings

Zacks
·
06 Feb

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Thursday

MT Newswires Live
·
06 Feb

Bristol Myers Squibb Warns Near-Term Impact Due To Generics On 2025 Sales Forecast, Outlines $2 Billion In Additional Cost Cuts

Benzinga
·
06 Feb

Bristol Myers Squibb Tops Q4 Estimates

Motley Fool
·
06 Feb

Bristol-Myers Squibb Stock Falls on Surprisingly Weak Guidance -- WSJ

Dow Jones
·
06 Feb

Bristol-Myers Squibb Reports Strong Q4 2024 Financial Results

TIPRANKS
·
06 Feb

Bristol-Myers Squibb Co (BMY) Q4 Earnings: Revenue Surpasses Estimates at $12.3 Billion, Non-GAAP EPS Beats at $1.67

GuruFocus
·
06 Feb

Bristol Myers misses expectations for 2025 guidance, shares fall

Investing.com
·
06 Feb

Stock Track | Bristol-Myers Squibb Plunges 5.38% Pre-Market on Disappointing 2025 Revenue Guidance

Stock Track
·
06 Feb

Bristol-Myers Squibb's Q4 Non-GAAP Earnings Decline, Revenue Increases

MT Newswires Live
·
06 Feb

BUZZ-Bristol Myers falls on downbeat 2025 profit, revenue forecast

Reuters
·
06 Feb

GUIDANCE: (BMY) Bristol-Myers Squibb Expects Full Year 2025 Revenue $45.5 Billion, vs. FactSet Est of $46.29 Billion

MT Newswires Live
·
06 Feb